Biotage AB (publ) (LON:0GRP)
140.00
+0.29 (0.21%)
At close: Apr 24, 2025
Biotage AB Revenue
Biotage AB had revenue of 385.00M SEK in the quarter ending March 31, 2025, a decrease of -19.79%. This brings the company's revenue in the last twelve months to 1.96B, down -1.01% year-over-year. In the year 2024, Biotage AB had annual revenue of 2.06B with 10.42% growth.
Revenue (ttm)
1.96B SEK
Revenue Growth
-1.01%
P/S Ratio
5.79
Revenue / Employee
2.88M SEK
Employees
680
Market Cap
875.39M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.06B | 194.00M | 10.42% |
Dec 31, 2023 | 1.86B | 296.00M | 18.90% |
Dec 31, 2022 | 1.57B | 334.00M | 27.11% |
Dec 31, 2021 | 1.23B | 140.00M | 12.82% |
Dec 31, 2020 | 1.09B | -9.37M | -0.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |